CD4 and myeloid sarcoma: All the patients were white (therefore the effect of race was not explored), there was no data available assessing BMI of healthy donors and pre- and post-sorted CD4 + T-cells were not assessed for potential loss of small subset populations such as CD56 + CD4 + T-cells, known to be dysregulated in some patients with MS, that could potentially influence the data [72].